Spiriva Respimat (Boehringer Ingelheim Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the Spiriva Respimat drug offered from Boehringer Ingelheim Pharmaceuticals, Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Boehringer Ingelheim Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: tiotropium bromide inhalation spray
SUBSTANCE NAME: TIOTROPIUM BROMIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-09-30
END MARKETING DATE: 0000-00-00


Spiriva Respimat HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSpiriva Respimat from Boehringer Ingelheim Pharmaceuticals, Inc.
LABELER NAME: Boehringer Ingelheim Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 3.124(ug/1)
START MARKETING DATE: 2014-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0597-0100_7c99bf78-d9e2-1b8e-e5ec-d56593430923
PRODUCT NDC: 0597-0100
APPLICATION NUMBER: NDA021936

Other TIOTROPIUM BROMIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Boehringer Ingelheim Pharmaceuticals, Inc.Spiriva Respimat